Concepedia

Annika Dotevall

AD

18

Publications

4.6K

Citations

17

H-Index

1987

Active since

Affiliations

Sahlgrenska University Hospital(Current)

University of Gothenburg

AstraZeneca (Sweden)

Université Laval

Semmelweis University

Annika Dotevall is an author at Sahlgrenska University Hospital specializing in medicine, cardiovascular disease, and diabetes.

ORCID

Top concepts

Publications per year

1987–2020

18

Publications

18

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies

Karl Kristensen, Linda Englund‐Ögge, Verena Sengpiel et al. · Diabetologia · 2019 · 199 citations · Full text

Coffee and incidence of diabetes in Swedish women: a prospective 18‐year follow‐up study

Annika Rosengren, Annika Dotevall, Lars Wilhelmsen et al. · Journal of Internal Medicine · 2003 · 160 citations · Full text

Risk factors for cardiovascular disease during the period 1985–1995 in Göteborg, Sweden. The GOT‐MONICA Project

Lars Wilhelmsen, S. Johansson, Annika Rosengren et al. · Journal of Internal Medicine · 1997 · 136 citations · Full text

Rows per page

1–5 of 18